基于DRGs的4例疑難腫瘤編碼分析報(bào)告

【摘要】  通過對(duì)4例臨床疑難神經(jīng)源性腫瘤的編碼進(jìn)行分析，并對(duì)其查找方法進(jìn)行探討，為提高臨床腫瘤編碼準(zhǔn)確性提供參考依據(jù)，推動(dòng)DRGs醫(yī)保支付下的臨床合理用藥水平。

【關(guān)鍵詞】  DRGs；ICD；腫瘤編碼；臨床合理用藥

中圖分類號(hào)  R197.323    文獻(xiàn)標(biāo)識(shí)碼  A    文章編號(hào)  1671-0223（2023）19--03

Coding analysis report of 4 difficult tumors based on DRGs Wang Shuaifei， Yi Dongmin， Meng Huanhuan， Wei Qiaolin， Ying Jie. Department of Pharmacy， Sir Run Run Shaw Hospital， Zhejiang University School of Medicine， Hangzhou 310016， China

【Abstract】  By analyzing the coding of four clinically difficult neurogenic tumors and discussing their search methods， this paper provides a reference for improving the accuracy of clinical tumor coding and promotes the level of clinical rational use of drugs under DRGs medical insurance payment.

【Key words】   DRGs; ICD; Tumor codig; Clinical rational use of drugs

國(guó)際疾病分類（international classification of diseases， ICD）是世界衛(wèi)生組織發(fā)布的國(guó)際權(quán)威疾病分類系統(tǒng)，有利于國(guó)際間疾病信息的交流與分享、醫(yī)療質(zhì)量管理的提升以及醫(yī)保支付的合理化改革等[1-3]。（剩余6582字）